- Home
- PHAT vs WOLF Comparison
PHAT vs WOLF Comparison
Compare PHAT & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- WOLF
- Stock Information
- Founded
- PHAT 2018
- WOLF 1987
- Country
- PHAT United States
- WOLF United States
- Employees
- PHAT N/A
- WOLF N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- WOLF Semiconductors
- Sector
- PHAT Health Care
- WOLF Technology
- Exchange
- PHAT Nasdaq
- WOLF Nasdaq
- Market Cap
- PHAT 942.6M
- WOLF 838.3M
- IPO Year
- PHAT 2019
- WOLF 1993
- Fundamental
- Price
- PHAT $14.85
- WOLF $17.38
- Analyst Decision
- PHAT Strong Buy
- WOLF Hold
- Analyst Count
- PHAT 5
- WOLF 8
- Target Price
- PHAT $17.60
- WOLF $9.86
- AVG Volume (30 Days)
- PHAT 983.2K
- WOLF 2.3M
- Earning Date
- PHAT 10-30-2025
- WOLF 10-29-2025
- Dividend Yield
- PHAT N/A
- WOLF N/A
- EPS Growth
- PHAT N/A
- WOLF N/A
- EPS
- PHAT N/A
- WOLF N/A
- Revenue
- PHAT $147,190,000.00
- WOLF $759,700,000.00
- Revenue This Year
- PHAT $218.38
- WOLF $16.42
- Revenue Next Year
- PHAT $87.14
- WOLF N/A
- P/E Ratio
- PHAT N/A
- WOLF N/A
- Revenue Growth
- PHAT 460.30
- WOLF N/A
- 52 Week Low
- PHAT $2.21
- WOLF $8.05
- 52 Week High
- PHAT $16.08
- WOLF $36.60
- Technical
- Relative Strength Index (RSI)
- PHAT 64.62
- WOLF 38.54
- Support Level
- PHAT $14.12
- WOLF $17.14
- Resistance Level
- PHAT $15.28
- WOLF $18.70
- Average True Range (ATR)
- PHAT 0.93
- WOLF 1.84
- MACD
- PHAT 0.07
- WOLF -0.90
- Stochastic Oscillator
- PHAT 82.58
- WOLF 5.83
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.